Inclusion Criteria

Inclusion criteria:

- Male or female patients 18 years or older

- Histologically documented advanced solid tumor, who have failed standard systemic
therapy, or for whom standard systemic therapy does not exist

- Life expectancy of 3 months or more

- Patients with adequate hematologic parameters

Exclusion criteria:

- Hypersensitivity to midazolam or omeprazole or related compounds

- Female patients who are pregnant or breast-feeding.

- Patients with a severe and/or uncontrolled medical disease

- Patients with a known diagnosis of human immunodeficiency virus (HIV) infection

- Patients having received an investigational agent within 30 days prior to study entry

Other protocol defined inclusion/exclusion criteria may apply.